Ayugen Biosciences Private Limited, a active private limited company, was established on 20 June 2005 in Nagar, Pune - 411 005., Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85199PN2005PTC020901. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.17 M.
It upholds a compliant status. Its leadership includes Manish Sampat Pungliya (Director), Sampat Nensukh Pungliya (Director). Past directors included Krishnan Nandabalan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 562/1, Jadav Bhuvan, Shivajinagar, Pune - 411 005., Nagar, Pune - 411 005., Maharashtra.
U85199PN2005PTC020901
020901
20 June 2005
₹1.50 M
₹1.17 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ayugen Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Sampat Pungliya | Director | 20 Jun 2005 | Current |
| Sampat Nensukh Pungliya | Director | 20 Jul 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Nov 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ayugen Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.29% decrease. The company also saw a substantial fall in profitability, with a 128.72% decrease in profit. The company's net worth dipped by a decrease of 9.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ayugen Biosciences had a public holding of 18.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ayugen Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ayugen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayugen Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ayugen Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Ayugen Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
Sampat Nensukh Pungliya was appointed as a Director was appointed as a Director on 20 Jul 2006 & has been associated with this company since 19 years 4 months . was recorded as a recent event.
The activity Manish Sampat Pungliya was appointed as a Director was appointed as a Director on 20 Jun 2005 & has been associated with this company since 20 years 5 months . was completed.
Ayugen Biosciences Private Limited was registered on 20 Jun 2005 with Roc Pune & aged 20 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Ayugen Biosciences Private Limited is U85199PN2005PTC020901.
Ayugen Biosciences Private Limited is headquartered at 562/1, Jadav Bhuvan, Shivajinagar, Pune - 411 005., Nagar, Pune - 411 005., Maharashtra.
Ayugen Biosciences Private Limited was incorporated on 20 June 2005.
The current directors of Ayugen Biosciences Private Limited are
The primary industry of Ayugen Biosciences Private Limited is Hospital And Medical Care.
Ayugen Biosciences Private Limited is unlisted.
The authorized capital of Ayugen Biosciences Private Limited is ₹1.50 M, and the paid-up capital is ₹1.17 M.
The compliance status of Ayugen Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX